Maple Syrup Urine Disease: Diffusion-Weighted and Diffusion-Tensor Magnetic Resonance Imaging Findings

Journal of Computer Assisted Tomography

Volumn 28, Issue 1, 2004, Pages 93-97

  Parmar, Hemant ^a   Sitoh, Yih Yian ^a   Ho, Ling ^b  

^a NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^b KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

Author keywords

Diffusion tensor imaging; Diffusion weighted imaging; Magnetic resonance imaging; Maple syrup urine disease

Indexed keywords

BODY FLUIDS; BRAIN; DIAGNOSIS; DIFFUSION TENSOR IMAGING; MAGNETISM; RESONANCE; SURFACE DIFFUSION; TENSORS;

% REDUCTIONS; APPARENT DIFFUSION COEFFICIENT; BRAINSTEM; CORONA RADIATA; DIFFUSION WEIGHTED IMAGES; DIFFUSION WEIGHTED IMAGING; DIFFUSION-TENSOR MAGNETIC RESONANCE IMAGING; INTERNAL CAPSULES; MAPLE SYRUP URINE DISEASE; WHITE MATTER;

MAGNETIC RESONANCE IMAGING;

AMINO ACID; BRANCHED CHAIN AMINO ACID; ISOLEUCINE; LEUCINE; VALINE;

AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; AMINO ACID URINE LEVEL; ANISOTROPY; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BRAIN STEM; CAPSULA INTERNA; CASE REPORT; CEREBELLUM; DIAGNOSTIC IMAGING; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; INBORN ERROR OF METABOLISM; MAPLE SYRUP URINE DISEASE; NEURORADIOLOGY; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; THALAMUS; WHITE MATTER;

EID: 0347986690     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004728-200401000-00015     Document Type: Article

References (26)

1. Danner DJ, Elhas LJ II. In: Scriver CR, Beaudet AL, Sly WS, et al, eds. The Metabolic Basis of Inherited Diseases. New York: McGraw-Hill; 1989:671-692.
2. Menkes JH, Hurst PL, Craig JM. A new syndrome: progressive familial infantile cerebral dysfunction associated with unusual urinary substance. Pediatrics. 1954;14:462-464.
3. Dancis J, Hutzler J, Synderman SE, et al. Enzyme activity in classic and variant forms of maple syrup urine disease. J Pediatr. 1972;81:312-320.
4. Wendel U. In: Fernandes J, Saudubray JM, Tada K, eds. Inborn Metabolic Diseases. Diagnosis and Treatment. Berlin: Springer-Verlag; 1990:263-270.
5. Muller K, Kahn T, Wendel U. Is demyelination a feature of maple syrup urine disease? Pediatr Neurol. 1993;9:375-382.
6. Basser PJ, Mattiello J, Lebihan D. Estimation of the effective self-diffusion tensor from the NMR spin echo. J Magn Reson B. 1994;103: 247-254.
7. Brismar J, Aqeel A, Brismar G, et al. Maple syrup urine disease: findings on CT and MR scans of the brain in 10 infants. AJNR Am J Neuroradiol. 1990;11:1219-1228.
8. Taccone A, Schiaffino MC, Cerone R, et al. Completed tomography in maple syrup urine disease. Eur J Radiol. 1992;14:207-212.
9. Uziel G, Savoiardo M, Nardocci N. CT and MRI in maple syrup urine disease. Neurology. 1998;38:486-488.
10. Jan W, Zimmerman RA, Wang ZJ, et al. MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation. Neuroradiol. 2003;45:393-399.
11. Sener RN. Diffusion magnetic resonance imaging in intermediate form of maple syrup urine disease. J Neuroimaging. 2002;12:368-370.
12. Cavalleri F, Berardi A, Burlina AB, et al. Diffusion-weighted MRI of maple syrup urine disease encephalopathy. Neuroradiology. 2002;44:499-502.
13. Neil JJ, Shiran SI, McKinstry RC, et al. Normal brain in human newborns: apparent diffusion coefficient and diffusion anisotropy measured by using diffusion tensor MR imaging. Radiology. 1998;209:57-66.
14. McGraw P, Liang L, Provenzale JM. Evaluation of normal age-related changes in anisotropy during infancy and childhood as shown by diffusion tensor imaging. AJR Am J Roentgenol. 2002;179:1515-1522.
15. Chuang DT, Shis VE. In: Scriver CR, Beardet Al, Sly WS, et al, eds. The Metabolic and Molecular Basis of Inherited Disease. New York: McGraw-Hill; 1995:1239-1277.
16. Sweetman L, Hass RH. In: Berg BO, ed. Neurologic Aspects of Pediatrics. Boston: Butterworth-Heinemann; 1992:3-32.
17. Kendall BE. Disorders of lysosomes, peroxisomes and mitochondria. AJNR Am J Neuroradiol. 1992;13:621-653.
18. Van der Knaap MS, Valk J. Magnetic Resonance of Myelin, Myelination, and Myelin Disorders. 2nd ed. Berlin: Springer; 1995.
19. Dreyfus PM, Prensky AL. Further observations on the biochemical lesion in maple syrup urine disease. Nature. 1967;214:276.
20. Lagenbeck U. In: Adibi SA, Fekl W, Lagenbeck U, et al, eds. Branched chain amino and keto acids in health and disease. Vol 1. Basel: Karger; 1984:315-334.
21. Huang Y, Zielke HR, Tildon JT, et al. Elevation of amino acids in interstitial space of the rat brain following infusion of large neutral amino and keto acids by microdialysis: leucine infusion. Dev Neurosci. 1996; 18: 415-419.
22. Kamei A, Takashima S, Chan F, et al. Abnormal dendritic development in maple syrup urine disease. Pediatr Neurol. 1992;8:145-147.
23. Silberman J, Daneis J, Feigin IH. Neuropathological observations in maple syrup urine disease. Arch Neurol. 1961;5:351-363.
24. Menkes JH, Philippart M, Fiol RE. Cerebral lipids in maple syrup disease. J Pediatr. 1965;66:584-594.
25. Prensky AL, Carr S, Moser HW. Development of myelin in inherited disorders of amino acid metabolism. Arch Neurol. 1968;19:552-558.
26. Schaefer PW, Grant PE, Gonzalez RG. Diffusion-weighted MR imaging of the brain. Radiology. 2000;217:331-345.